Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: TonyL who wrote (732)	5/14/1999 2:45:00 PM
From: StockMiser	Read Replies (2) \| Respond to of 2344

No relevance that I can see...to either bits of news. Theratope isn't chemo, but it can be used along with chemo and many other therapies. As for Altarex... The short story is that they were started by Biomira scientists, and licensed some patented technologies from Biomira (none of which are relevant to any products Biomira has in it's product pipeline, but are critical to Altarex's R&D). There is some kind of dispute over the terms of the license (Biomira appears to have not extended the license). Altarex is suing Biomira to allegedly enforce the license contract. Biomira is suing Altarex for outright patent infringement to the tune of $200 million. IMHO, worst case is that Biomira continues licensing to Altarex. Best case is that Biomira ends up owning Altarex along with their product pipeline. SM